Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 320

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity

Open access
Mayer, Ingrid A., Abramson, Vandana G., Lehmann, Brian D., Pietenpol, Jennifer A.·2014·Clinical Cancer Research

Abstract

Triple-negative breast cancer (TNBC) is a heterogeneous disease; gene expression analyses recently identified six distinct TNBC subtypes, each displaying a unique biology. Exploring novel approaches to treatment of these subtypes is critical because less than 30% of women with metastatic breast cancer survive five years and virtually all women with metastatic TNBC will ultimately die of their disease despite systemic therapy. To date, not a single targeted therapy has been approved for the treatment of TNBC and cytotoxic chemotherapy remains the standard treatment. We discuss the current and upcoming therapeutic strategies being explored in an attempt to “target” TNBC. Clin Cancer Res; 20(4); 782–90. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-13-0583

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 320

Metadata

Authors
Mayer, I. A., Abramson, V. G., Lehmann, B. D., & Pietenpol, J. A.
Venue
Clinical Cancer Research
Published
2014-02-15
Volume
20
Issue
4
Pages
782-790
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2165936545
Cited by
320
References
50
FWCI
11.27
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-13-0583
The paper
Mayer, I. A., Abramson, V. G., Lehmann, B. D., & Pietenpol, J. A. (2014). New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-13-0583

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.